Table 2 The proportion of B (CD19) and T (CD3) lymphocytes within the population of peripheral blood mononuclear cells from subjects studied prior to (baseline), and 2 hr after treatment. Results are presented as means ± SD.
Group | Phenotype [%] | |||
|---|---|---|---|---|
| Â | CD 19 (range) | CD3 (range) | ||
| Â | Baseline | 2 hr | Baseline | 2 hr |
VC | 9.2 ± 3 (6 - 14) | 10.6 ± 4 (6 - 16) | 77 ± 12 (67 - 90) | 76 ± 11 (68 - 88) |
SMT-NC | 10.8 ± 3 (6 - 11) | 11.8 ± 5 (7 - 17) | 74 ± 14 (64 - 89) | 71 ± 16 (58 - 84) |
SMT-C | 11.0 ± 4 (7 - 15) | 11.4 ± 6 (6 - 17) | 72 ± 15 (62 - 88) | 75 ± 12 (64 - 94) |